Prostate cancer treatment: An encouraging combination therapy
A trio of drugs could delay the progression of metastatic castration-resistant prostate cancer.
Nov 3, 2021
0
12
A trio of drugs could delay the progression of metastatic castration-resistant prostate cancer.
Nov 3, 2021
0
12
A team of researchers investigating how a certain type of drugs can kill cells has discovered that these drugs can do more harm than good when used in combination with other cancer treatments.
Jul 24, 2020
0
2
PHILADELPHIA -A new large population-based study from the Sidney Kimmel Cancer Center—Jefferson Health shows that novel oral androgen signaling inhibitor therapies are associated with an increased risk of death in patients ...
Aug 13, 2019
0
0
It used to be a statistical fact that African-American men fared worse than whites when battling prostate cancer.
Feb 12, 2019
0
6
A prostate cancer drug has been provisionally rejected as a first-line treatment on the NHS in England.
Jun 8, 2018
0
1
Adding abiraterone acetate (Zytiga) plus prednisone to standard hormonal therapy for men newly diagnosed with high-risk, metastatic prostate cancer lowers the chance of death by 38%. In a phase III clinical trial of 1,200 ...
Jun 5, 2017
0
0
Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent, according to the results of one of the largest ever clinical trials for prostate cancer presented at the ...
Jun 3, 2017
0
113
Patients with metastatic prostate cancer whose PSA levels remain high despite initial hormone treatments have historically had poor prognosis, with survival typically in the 1-2 year range. Results of a 40-person clinical ...
Apr 5, 2017
0
1
A study presented at the 2016 Genitourinary Cancers Symposium shows that 40 percent of patients with castration-resistant metastatic prostate cancer (mCRPC) treated with docetaxel following abiraterone had at least 50 percent ...
Jan 11, 2016
0
1
In 1048 prostate cancer patients previously treated with docetaxel and 996 metastatic, castration-resistant patients, treatment with the androgen-lowering drug abiraterone acetate (Zytiga) led to longer overall disease control, ...
Dec 3, 2015
0
0